Mesoblast limited (OTCMKTS:MBLTY) received a $14.00 price target from Maxim Group in a report issued on Thursday. The brokerage presently has a a “buy” rating on the stock. Maxim Group’s target price suggests a potential upside of 13.54% from the company’s previous close.
A number of other research analysts have also commented on MBLTY. Credit Suisse Group AG lowered Mesoblast limited to a “hold” rating in a research report on Wednesday, June 15th. JPMorgan Chase & Co. reiterated a “hold” rating on shares of Mesoblast limited in a research report on Wednesday, June 15th.
Shares of Mesoblast limited (OTCMKTS:MBLTY) remained flat at $12.33 during midday trading on Thursday. Mesoblast limited has a 12 month low of $10.27 and a 12 month high of $19.00. The company’s 50-day moving average is $12.26 and its 200-day moving average is $13.71.